abstract |
The present invention is directed to a compound of formula (I): wherein R1 to R3, A, X and n are as defined herein. The compound of the formula (I) is useful as an inhibitor of leukotriene A4 hydrolase (LTA4H) and for treating LTA4H related disorders. The invention also relates to pharmaceutical compositions comprising the compounds of the formula (I), methods of using the compounds to treat various diseases and conditions, and processes for preparing such compounds. |